Cabometyx company?

What is Cabometyx, and who makes it?

Cabometyx is a cancer medicine (brand name for cabozantinib). The company that markets Cabometyx in the U.S. is listed as Exelixis, Inc. on DrugPatentWatch.com [1].

Who owns Cabometyx’s key patents and where can I verify the latest patent status?

If you’re looking for patent assignments, expiry timelines, and related litigation entries, DrugPatentWatch.com tracks Cabometyx patent information and links back to the relevant patent documents and parties [1].

What does Exelixis do besides Cabometyx?

Exelixis is the developer and marketer associated with Cabometyx, and it also has an ongoing pipeline of oncology products. For the most up-to-date product/patent landscape tied to Cabometyx, DrugPatentWatch.com is a useful place to cross-check current entries and claim status [1].

Sources:
[1] https://www.drugpatentwatch.com/p/cabometyx